Literature DB >> 15358698

Spirometric reference equations for European females and males aged 65-85 yrs.

F García-Río1, J M Pino, A Dorgham, A Alonso, J Villamor.   

Abstract

The aim of this study was to describe spirometric reference equations for healthy never-smoking European adults aged 65-85 yrs and to compare the predicted values of this sample with those from other studies including middle-aged and/or older adults. Reference equations and normal ranges for forced expiratory volume in one second (FEV1), forced vital capacity (FVC), forced expiratory volume in six seconds (FEV6), FEV1/FVC ratio and FEV1/FEV6 ratio were derived from a healthy subgroup of 458 subjects aged 65-85 yrs. Spirometry examinations followed the 1994 American Thoracic Society recommendations and the quality of the data was continuously monitored and maintained. Reference values and lower limits of normal were derived using a piecewise polynomial model with age and height as predictors. The reference values of FEV1 and FVC from the present study were higher than those given by prediction equations from the European Community for Coal and Steel. By contrast, use of prediction equations from Caucasian-American elderly subjects (Cardiovascular Health Study) consistently overpredicted FVC and FEV1 in females by 8.5 and 2.1%, respectively. In males, equations from the Cardiovascular Health Study overpredicted FVC by 2.8%, whilst underpredicting FEV1 by 2.5%. In conclusion, these results underscore the importance of using prediction equations appropriate to the origin, age and height characteristics of the subjects being studied.

Mesh:

Year:  2004        PMID: 15358698     DOI: 10.1183/09031936.04.00088403

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  28 in total

Review 1.  Spirometry.

Authors:  Theodore G Liou; Richard E Kanner
Journal:  Clin Rev Allergy Immunol       Date:  2009-04-04       Impact factor: 8.667

2.  Respiratory impairment and mortality in older persons: a novel spirometric approach.

Authors:  Carlos A Vaz Fragoso; Thomas M Gill; Gail McAvay; Henry Klar Yaggi; Peter H Van Ness; John Concato
Journal:  J Investig Med       Date:  2011-10       Impact factor: 2.895

3.  [Pulmonary diseases in the elderly].

Authors:  M Gogol; H J Heppner
Journal:  Z Gerontol Geriatr       Date:  2011-08       Impact factor: 1.281

Review 4.  Respiratory impairment and the aging lung: a novel paradigm for assessing pulmonary function.

Authors:  Carlos A Vaz Fragoso; Thomas M Gill
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2011-12-01       Impact factor: 6.053

5.  Best lung function equations for the very elderly selected by survival analysis.

Authors:  Martin R Miller; Mikael Thinggaard; Kaare Christensen; Ole F Pedersen; Torben Sigsgaard
Journal:  Eur Respir J       Date:  2014-01-31       Impact factor: 16.671

6.  Feasible and simple exclusion criteria for pulmonary reference populations.

Authors:  Ane Johannessen; Ernst R Omenaas; Geir Egil Eide; Per S Bakke; Amund Gulsvik
Journal:  Thorax       Date:  2007-03-27       Impact factor: 9.139

7.  FEV(6) as screening tool in spirometric diagnosis of obstructive airway disease.

Authors:  P Adithya Malolan; Vishak Acharya; B Unnikrishnan
Journal:  Lung India       Date:  2010-04

8.  Reporting peak expiratory flow in older persons.

Authors:  Carlos A Vaz Fragoso; Evelyne A Gahbauer; Peter H Van Ness; Thomas M Gill
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2007-10       Impact factor: 6.053

Review 9.  What defines abnormal lung function in older adults with chronic obstructive pulmonary disease?

Authors:  Nitin Y Bhatt; Karen L Wood
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

10.  Defining chronic obstructive pulmonary disease in older persons.

Authors:  Carlos A Vaz Fragoso; John Concato; Gail McAvay; Peter H Van Ness; Carolyn L Rochester; H Klar Yaggi; Thomas M Gill
Journal:  Respir Med       Date:  2009-05-21       Impact factor: 3.415

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.